Genzyme taps Meeker for new COO post; Amphastar hired P.I. to probe FDA's Woodcock;

 @FiercePharma: FDA warning letter requires early exec presence, artful response. Article | Follow @FiercePharma

> Genzyme, the embattled biotechnology company, says it has created the new position of chief operating officer and appointed executive vice president David Meeker to the post. Release | Report 

> For more than two months in late 2008, private investigators working for generics maker Amphastar gathered information on CDER's Janet Woodcock, unearthing details about her family and re-tracing her steps on a business trip to Thailand. Report

> Boehringer Ingelheim's prostate drug Flomax, previously available only by prescription, will now be sold over the counter in U.K. pharmacies. Report

> Duodart, a two-in-one prostrate drug from GlaxoSmithKline, has been approved in Europe. Report

> Allergan, the Irvine-based maker of Botox and other drugs, had its outlook raised by Fitch Ratings. Report

Biotech News

 @FierceBiotech: New Boehringer fund to invest $135M in biotech, start-ups. Report | Follow @FierceBiotech

 @JohnCFierce: Two things to highlight on this Glaxo/Isis deal. Glaxo is showing its love of rare diseases, and Isis gets marks for staying in control to proof-of-concept. | Follow @JohnCFierce

> ArQule shares skyrocket on promising Phase II lung cancer data. Report

> Vivus hands back rights to testosterone therapy. Item

> Experts fear gene patent ruling's impact on biotech. Story

> Eisai pursues blockbuster approvals for breast cancer drug. Article

> Isis bags $1.53B rare disease development deal with GSK. Report

Medical Device News

> Report: Feds scrutinizing Boston Scientific recall. Article

> Boston Scientific's CEO gets $33.4 million; Baxter chief's pay falls. Story

>  A Johnson & Johnson unit received an offer from private-equity firm GTCR Golder Rauner for its breast-care business. Report

And Finally... The ability to show the quality of connections within the brain is leading to better understanding of creativity, intelligence and mental illness. Report